Zobrazeno 1 - 9
of 9
pro vyhledávání: '"O. I. Borisov"'
Publikováno v:
Naučno-tehničeskij Vestnik Informacionnyh Tehnologij, Mehaniki i Optiki, Vol 16, Iss 4, Pp 749-752 (2016)
The paper presents results of work on creation of technical vision systems within the training complex for the verification of control systems by the model of surface vessel. The developed system allows determination of the coordinates and orientatio
Externí odkaz:
https://doaj.org/article/f59df33adf9844bea35c3da25a81948d
Publikováno v:
Naučno-tehničeskij Vestnik Informacionnyh Tehnologij, Mehaniki i Optiki, Vol 15, Iss 6, Pp 1045-1053 (2015)
Subject of Research. The paper presents an output control approach for a class of nonlinear MIMO (Multiple Input Multiple Output) systems. Quadrocopter is chosen to illustrate proposed adaptive control approach based on the high-gain principle, the s
Externí odkaz:
https://doaj.org/article/fca4576071b94e4b910f5f97b4849475
Autor:
E M Naidenova, I V Osipova, M I Sadriddinov, O. V. Karamova, A V Pavlova, O I Borisov, Arthur Gibadullin
Publikováno v:
Journal of Physics: Conference Series. 1691:012098
The article is devoted to the development of digital competencies among students of higher educational institutions. The study analyzed the digital competencies of students and the level of Internet use for receiving services and their self-education
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::424a6920ea188080ea12df541bf8b458
https://doi.org/10.1088/1742-6596/1691/1/012098
https://doi.org/10.1088/1742-6596/1691/1/012098
Publikováno v:
IOP Conference Series: Earth and Environmental Science. 421:032041
Digitalization of manufacturing industries is becoming the engine of digital transformation of the entire economy. The essence of the digitalization process in the context of the deployment of the Fourth Industrial Revolution is the process of penetr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0306426b9fb573be5fc425e3632c13a1
https://doi.org/10.1088/1755-1315/421/3/032041
https://doi.org/10.1088/1755-1315/421/3/032041
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 150-154 (2021)
The optimal hepatocellular cancer (HCC) therapy remains a challenge. Due to checkpoint inhibitors patients with intolerance to the targeted therapy and or those with the impaired liver function can get an appropriate drug therapy. This clinical obser
Externí odkaz:
https://doaj.org/article/7d3b533bad6847ca98344d2b18409f5a
Autor:
D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, V. V. Breder, M. S. Ardzinba, E. V. Reutova, O. I. Borisova
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 18-24 (2021)
Introduction. Lung cancer remains the one of the most common and fatal cancers in the world. For a long time, chemotherapy was the only treatment option for metastatic lung cancer. Currently, immunotherapy became the one of the preferred options of t
Externí odkaz:
https://doaj.org/article/2147954dcc9547a6a6fbf739228a60c2
Autor:
D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, O. I. Borisova, V. V. Breder, E. V. Reutova, M. F. Beloyartseva, S. Yu. Kruteleva, I. A. Dzhanyan
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 16-24 (2020)
Recently immune checkpoint inhibitors amazingly changed the landscape of cancer therapy worldwide. The number of immune checkpoint molecules in clinical practice is constantly increasing. There are some monoclonal antibodies recently registered in th
Externí odkaz:
https://doaj.org/article/87179a43c93546bfb40f6596a9ef6212
Autor:
D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, V. V. Breder, E. V. Reutova, O. I. Borisova, M. S. Ardzinba
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 10-14 (2019)
Now the number of patients receiving immunotherapy with checkpoint inhibitors is growing. At the same time, clinicians increasingly encounter such a clinical phenomenon as pseudoprogression. Nowadays we have no radiological evidences of pseudoprogres
Externí odkaz:
https://doaj.org/article/4fc44ed8e3be429aa9faa26beb00e920
Autor:
E. M. Zhidkova, K. A. Kuzin, L. R. Tilova, A. V. Savinkova, O. I. Borisova, M. D. Lavrova, V. P. Maximova, K. I. Kirsanov, M. G. Yakubovskaya, E. A. Lesovaya
Publikováno v:
Сибирский онкологический журнал, Vol 16, Iss 6, Pp 41-46 (2017)
Glucocorticoids (GCs) are often used as an adjuvant therapy to reduce the adverse effects of chemotherapy in breast cancer patients. Moreover, GCs can display pro-proliferative or anti-proliferative effects on BC cells depending on their molecular su
Externí odkaz:
https://doaj.org/article/4d64a0da2fe24c45b32fe739585c115d